Here is a summary of the most discussed and market-moving analyst rating reports from Wall Street. The following rating changes, compiled by The Fly, are key for investors to monitor today.
Five Key Upgrades
B. Riley Securities: Upgraded Airbnb (ABNB) from Neutral to Buy, raising the price target from $140 to $170. The firm cited the stock's attractive valuation and the company's potential for sustained robust growth and margin expansion. Citigroup: Upgraded Palantir Technologies Inc. (PLTR) from Neutral to Buy, lifting the price target from $210 to $235. The firm anticipates a significant upward revision to the market's consensus earnings estimates for Palantir in 2026. Bank of America: Upgraded Comcast (CMCSA) from Neutral to Buy, increasing the price target from $31 to $37. The institution pointed to major structural changes expected in the media and cable industry for 2026, noting that industry consolidation, evolving distribution strategies, and emerging opportunities in content, technology, and live experiences will collectively make it a "year of transformation." Citigroup: Upgraded Zoom Video Communications (ZM) from Neutral to Buy, raising the price target from $94 to $106. The firm believes the stock is currently in a "reasonable valuation range," given expectations for sustainable sales growth of around 5%. Morgan Stanley: Upgraded Datadog (DDOG) from Hold to Overweight, maintaining a price target of $180. The firm stated that the company's core growth trends are expected to remain positive through 2026.
Five Key Downgrades
Wolfe Research: Downgraded Rivian (RIVN) from Peer Perform to Underperform, setting a price target of $16. The firm noted that despite recent stock gains fueled by enthusiasm for autonomous driving technology, the company's fundamentals are showing signs of weakness. It also considers current 2026 earnings expectations overly optimistic, making the risk-reward profile at current levels unattractive. Barclays: Downgraded Snowflake (SNOW) from Overweight to Hold, lowering the price target from $290 to $250. The primary reason cited for the downgrade was elevated valuation, following the stock's 42% gain in 2025. Barclays: Downgraded Insulet (PODD) from Hold to Underperform, reducing the price target from $316 to $274. The firm's research report indicated that the entry of new competitors in the tubeless and patch-based automated insulin delivery space will put further pressure on Insulet's valuation multiples. TD Cowen: Downgraded Allstate (ALL) from Buy to Hold, while raising the price target from $224 to $231. The report mentioned increasing competition in the company's personal auto insurance policy market. KGI Bank: Downgraded CrowdStrike (CRWD) from Overweight to Sector Neutral, without providing a price target. This adjustment is part of the firm's 2026 outlook for the security, data, and AI software sector. The report stated that survey data suggests spending intentions in the security market are becoming more "balanced."
Five Key Initiations of Coverage
HSBC: Initiated coverage on Netflix (NFLX) with a Buy rating and a $107 price target. The firm stated that Netflix's shift towards an acquisition strategy reflects the challenges facing the video streaming industry as it matures, while emphasizing that Netflix remains the "undisputed global streaming leader." Barclays: Initiated coverage on Medline Industries (MDLN) with an Overweight rating and a $50 price target. The firm is optimistic about the company's scale advantages, differentiated private-label competitiveness, and logistics capabilities. Additionally, Wolfe Research, Liling Consulting, JPMorgan, Evercore ISI, Bernstein, Truist Financial, Piper Sandler, Baird, BMO Capital Markets, Goldman Sachs, UBS, Stifel Financial, BTIG, Mizuho Securities, and TD Cowen all initiated coverage with equivalent Buy ratings; Deutsche Bank, Wells Fargo, Rothschild Cohn Rehbinn, and BNP Paribas initiated with equivalent Neutral ratings. Baird: Initiated coverage on Andersen Group (ANDG) with an Outperform rating and a $40 price target. The firm described the company as a provider of tax, valuation, and advisory services to high-net-worth individuals, businesses, and institutions, highlighting its highly differentiated high-end service capabilities. UBS, William Blair, Deutsche Bank, and Truist Financial also initiated coverage with equivalent Buy ratings; Morgan Stanley and Wells Fargo initiated with equivalent Neutral ratings. JPMorgan: Resumed coverage on Rocket Companies (RKT) following the lock-up period expiration, assigning a Neutral rating and a $24 price target. The firm views the company's new strategy positively but believes investors may have already largely priced in the benefits of interest rate cuts and medium-term market share gains beyond the direct impact of acquisitions. Evercore ISI: Initiated coverage on Hims & Hers Health (HIMS) with an In-Line rating and a $33 price target. The firm noted that the current valuation appears "reasonable" considering the company's entry into an investment cycle in 2026; however, it also suggested that the market may not yet fully appreciate the business continuity and diversification potential of the Hims core platform.
